DGK-α Antibodies

Santa Cruz Biotechnology provides a broad selection of DGK-α monoclonal antibodies for research focused on understanding diacylglycerol kinase alpha. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DGK-α plays a central role in lipid signaling pathways by converting diacylglycerol into phosphatidic acid, which regulates cellular processes such as proliferation, differentiation, and apoptosis. Research has shown DGK-α's significance in various physiological and pathological conditions, including cancer and cardiovascular diseases, making it a promising target for therapeutic interventions. Understanding DGK-α's molecular mechanisms and cellular functions can provide valuable insights into disease development and potential treatments. Advanced research techniques and reliable detection methods are essential for studying DGK-α's complex signaling networks and biological functions. Investigating DGK-α's role in different tissue types and disease states continues to reveal new therapeutic possibilities. DGK-α monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cellular signaling pathways and disease mechanisms.